HIVpages
Plain-English HIV information, treatment options and clinical trial search.
Medical disclaimer: HIVpages provides educational information only and does not provide medical advice, diagnosis or treatment. Always confirm treatment, pregnancy, prevention and clinical-trial decisions with a qualified healthcare professional.

HIV treatment matrix

This starter matrix lists common FDA-approved HIV medicines and fixed-dose combinations. It is intended as a readable reference, not prescribing guidance.

Treatment choices depend on viral load, resistance history, kidney/liver health, pregnancy, drug interactions, other conditions and patient preference.

Individual medicines by class

ClassGeneric nameBrand nameNotes
NRTIAbacavirZiagenOften abbreviated ABC.
NRTIEmtricitabineEmtrivaOften abbreviated FTC.
NRTILamivudineEpivirOften abbreviated 3TC.
NRTITenofovir disoproxil fumarateVireadOften abbreviated TDF.
NRTITenofovir alafenamideVemlidyOften abbreviated TAF.
NNRTIDoravirinePifeltroOften abbreviated DOR.
NNRTIEfavirenzSustivaOften abbreviated EFV.
NNRTIEtravirineIntelenceOften abbreviated ETR.
NNRTINevirapineViramuneOften abbreviated NVP.
NNRTIRilpivirineEdurantOften abbreviated RPV.
INSTIBictegravirPart of BiktarvyOften abbreviated BIC.
INSTICabotegravirVocabria / ApretudeOral and long-acting injectable uses differ.
INSTIDolutegravirTivicayOften abbreviated DTG.
INSTIElvitegravirPart of Stribild/GenvoyaUsed in fixed-dose combinations.
INSTIRaltegravirIsentressOften abbreviated RAL.
Protease inhibitorAtazanavirReyatazOften abbreviated ATV.
Protease inhibitorDarunavirPrezistaOften abbreviated DRV.
Protease inhibitorLopinavir/ritonavirKaletraCombination PI booster product.
Protease inhibitorRitonavirNorvirOften used as a booster.
Entry/fusion/attachmentEnfuvirtideFuzeonFusion inhibitor.
Entry/fusion/attachmentFostemsavirRukobiaAttachment inhibitor.
CCR5 antagonistMaravirocSelzentryRequires tropism testing.
Capsid inhibitorLenacapavirSunlencaLong-acting capsid inhibitor.
Pharmacokinetic enhancerCobicistatTybostBooster, not active against HIV alone.

Common fixed-dose combinations

Brand nameGeneric componentsNotes
Biktarvybictegravir / emtricitabine / tenofovir alafenamideSingle-tablet regimen.
Dovatodolutegravir / lamivudineTwo-drug single-tablet regimen for selected patients.
Triumeqabacavir / dolutegravir / lamivudineRequires consideration of abacavir suitability.
Delstrigodoravirine / lamivudine / tenofovir disoproxil fumarateSingle-tablet regimen.
Genvoyaelvitegravir / cobicistat / emtricitabine / tenofovir alafenamideBoosted INSTI regimen.
Stribildelvitegravir / cobicistat / emtricitabine / tenofovir disoproxil fumarateBoosted INSTI regimen.
Symtuzadarunavir / cobicistat / emtricitabine / tenofovir alafenamideBoosted PI single-tablet regimen.
Odefseyemtricitabine / rilpivirine / tenofovir alafenamideRilpivirine-based single-tablet regimen.
Julucadolutegravir / rilpivirineTwo-drug maintenance regimen.
Cabenuvacabotegravir / rilpivirineLong-acting injectable regimen.
Descovyemtricitabine / tenofovir alafenamideUsed in treatment combinations and PrEP in selected groups.
Truvadaemtricitabine / tenofovir disoproxil fumarateUsed in treatment combinations and PrEP.
Epzicom/Kivexaabacavir / lamivudineBrand varies by country.